The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of a telomerase-specific oncolytic adenovirus (OBP-301, Telomelysin) in combination with pembrolizumab in gastric and gastroesophageal junction adenocarcinoma.
 
Uqba Khan
No Relationships to Disclose
 
Talia Biran
Employment - Oncolys BioPharma
Travel, Accommodations, Expenses - Oncolys BioPharma
 
Allyson J. Ocean
No Relationships to Disclose
 
Elizabeta C. Popa
No Relationships to Disclose
 
Joseph T. Ruggiero
No Relationships to Disclose
 
Doru Paul
No Relationships to Disclose
 
Chelsea Garcia
No Relationships to Disclose
 
David Carr-Locke
No Relationships to Disclose
 
Reem Sharaiha
No Relationships to Disclose
 
Yasuo Urata
Employment - Oncolys BioPharma
 
Manish A. Shah
Consulting or Advisory Role - Astellas Pharma
Research Funding - Boston Biomedical (Inst); Gilead Sciences (Inst); Merck (Inst); Oncolys BioPharma (Inst)